Car­go Ther­a­peu­tics cuts lead CAR-T pro­gram, 50% of staff

Car­go Ther­a­peu­tics is stop­ping a Phase 2 study of an ex­per­i­men­tal CAR-T ther­a­py af­ter the tri­al gen­er­at­ed dis­ap­point­ing da­ta, and it’s lay­ing off about half …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER